| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |